2023-05-17 08:06:14 ET
- CASI Pharmaceuticals press release ( NASDAQ: CASI ): Q1 GAAP EPS of -$0.45.
- Revenue of $8.35M (-7.8% Y/Y).
For further details see:
CASI Pharmaceuticals GAAP EPS of -$0.45, revenue of $8.35M2023-05-17 08:06:14 ET
For further details see:
CASI Pharmaceuticals GAAP EPS of -$0.45, revenue of $8.35MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
Market:
CASI Pharmaceuticals Inc. Website:
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS PR Newswire BEIJING , April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercia...
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS PR Newswire BEIJING , March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing a...